In the SELECT trial, which included more than 17,000 patients with obesity and cardiovascular disease but not diabetes, semaglutide cut the rate of major cardiac events by 20%
GLP-1 receptor agonists are reasonable alternatives to SGLT-2 inhibitors in patients with similar risk profiles because this drug class also improves mortality, although to a lesser extent
Nair PMG, Choi J
Behind Semaglutide + NAD To truly appreciate the benefits of Semaglutide with NAD, its important to understand the scientific mechanisms at play
GLP-1 medications can make weight loss more manageable, while Potere Health MD provides Salt Lake City with the physician guidance, personalized dosing, and ongoing support you needwhether you visit us in the clinic or virtually
Once you do, you will be on the right path to taking advantage of this unique substance